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Abstract: Neurons in the embryonic and peripheral nervous system respond 
to injury by activating transcriptional programs supportive of axon growth, 
ultimately resulting in functional recovery. In contrast, neurons in the adult 
central nervous system (CNS) possess a limited capacity to regenerate axons 
after injury, fundamentally constraining repair. Activating pro-regenerative 
gene expression in CNS neurons is a promising therapeutic approach, but 
progress is hampered by incomplete knowledge of the relevant transcription 
factors. An emerging hypothesis is that factors implicated in cellular growth 
and motility outside the nervous system may also control axon growth in 
neurons. We therefore tested sixty-nine transcription factors, previously 
identified as possessing tumor suppressive or oncogenic properties in non-
neuronal cells, in assays of neurite outgrowth. This screen identified YAP1 and 
E2F1 as enhancers of neurite outgrowth, and PITX1, RBM14, ZBTB16, and 
HHEX as inhibitors. Follow-up experiments are focused on the tumor 
suppressor HHEX, one of the strongest growth inhibitors. HHEX is widely 
expressed in adult CNS neurons, including corticospinal tract neurons after 
spinal injury, but is present only in trace amounts in immature cortical 
neurons and adult peripheral neurons. HHEX overexpression in early postnatal 
cortical neurons reduced both initial axonogenesis and the rate of axon 
elongation, and domain deletion analysis strongly implicated transcriptional 
repression as the underlying mechanism. These findings suggest a role for 
HHEX in restricting axon growth in the developing CNS, and substantiate the 
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hypothesis that previously identified oncogenes and tumor suppressors can 
play conserved roles in axon extension. 
Keywords: Axon regeneration, Transcription factor, High content screening 
1. Introduction 
In contrast to the peripheral nervous system (PNS) and the 
developing central nervous system (CNS), axons in the mature CNS 
generally fail to regenerate after injury. While external inhibitory 
factors contribute (Case and Tessier-Lavigne, 2005; Yiu and He, 
2006), a major reason for regenerative failure is a loss of growth 
ability that is intrinsic to CNS neurons (Goldberg et al., 2002, 
Blackmore and Letourneau, 2006 and Sun and He, 2010). Intervening 
in the CNS cell body response, either by increasing pro-regenerative 
gene expression or eliminating growth-inhibitory gene expression, has 
emerged as a promising strategy to promote axon growth (Park et al., 
2008, Moore et al., 2009, Liu et al., 2010b and Blackmore et al., 
2012). Given the substantial amount and diversity of cellular material 
needed for axon growth, it is probable that multiple targets must be 
altered for optimal regeneration (Sun et al., 2011). Thus transcription 
factors (TFs), which coordinate the expression of multiple genes, are 
well suited to have a profound effect on axonal growth (Moore and 
Goldberg, 2011 and Patodia and Raivich, 2012). A number of TFs have 
been identified that regulate axon regeneration, but our understanding 
remains incomplete and additional transcriptional regulators of axon 
growth almost certainly await discovery (Moore and Goldberg, 2011). 
It has been proposed that cellular growth mechanisms present 
in replicating cells outside the nervous system are conserved in post-
mitotic neurons and may play key roles in axon growth (Park et al., 
2008). Tumor-suppressive factors that prevent aberrant proliferation 
in dividing cells may act to restrict axon growth in neurons, whereas 
factors with oncogenic properties may act to promote axon growth 
(Pomerantz and Blau, 2013). Supporting this concept, signaling 
pathways involved in cancer progression have been found to affect 
neurite outgrowth (Buchser et al., 2010), most notably the mTOR 
pathway (Park et al., 2008) and the oncogene MYC (Belin et al., 
2015). Furthermore, TFs such as KLF family members and Sox11, 
shown recently to promote CNS axon regeneration, are also well-
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studied in cancer biology (Blackmore et al., 2012 and Wang et al., 
2015). These findings suggest that additional transcription factors, 
identified previously as displaying oncogenic or tumor suppressive 
properties in mitotically active cells, may regulate axon extension in 
neurons. 
To test this hypothesis we adopted a high content screening 
strategy in which 69 TFs, implicated previously in cancer progression, 
were overexpressed in assays of neurite outgrowth. Nine of these TFs 
were found to significantly alter neurite length, of which a tumor 
suppressor called Hematopoietically Expressed Homeobox (HHEX) was 
among the most consistent and potent growth inhibitors. In follow-up 
experiments we confirmed strong suppression of axon growth by HHEX 
without a corresponding decrease in cell viability. Moreover, although 
HHEX has previously been described only in non-neuronal tissues, we 
show expression of HHEX in the CNS that is widespread and specific to 
neurons. In contrast we detected only low levels of HHEX in early 
postnatal CNS and adult PNS neurons, and found that forced elevation 
of HHEX expression reduces axon growth ability. Overall these data 
substantiate the mechanistic link between axon growth and general 
cellular growth at the level of transcriptional control, and suggest that 
the tumor suppressor HHEX may function as a novel transcriptional 
inhibitor of axon growth in the CNS. 
2. Methods 
2.1. Cloning and plasmid preparation 
For screening and cell viability experiments, DNA was prepared 
(QIAprep Spin Miniprep Kit, Qiagen 27106) from glycerol stocks of NIH 
Mammalian Genome Collection in pSPORT6-CMV expression vectors 
(Open Biosystems, ThermoFisher, Huntsville, Alabama) (Gerhard et 
al., 2004). To create constructs for domain mutation analysis, a 
CAMKIIa promoter sequence ((Zhang et al., 2007), Addgene #20944)) 
replaced the original CMV in pAAV-EBFP-2A-mCherry backbone 
(described previously, (Blackmore et al., 2012)), generating pAAV-
CAMKIIa-EBFP-2A-mCherry. Next, a Histone-2B sequence ((Kita-
Matsuo et al., 2009) (Addgene #21217)) was inserted 5′ to mCherry. 
cDNA encoding human HHEX (Accession BC050638) was purchased 
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from Open Biosystems. The open reading frame (aa 1–270) was PCR-
amplified and used to replace EBFP, creating CAMKIIa-HHEX-2A-H2B-
mCherry. To create additional constructs, full length HHEX was 
replaced with amino acids 137–270 (Homeodomain and Activation 
domain, HHEX-ΔN), HHEX-ΔN fused to an Engrailed domain, as 
described in Blackmore et al. (2012), or amino acids 1–210 
(repression domain and homeodomain, HHEX-ΔC). DNA was prepared 
by EndoFree Plasmid Maxi Kit (Qiagen 12362) and diluted to 1 μg/μl in 
endotoxin-free TE buffer. 
2.2. Cortical cell dissociation, transfection, and culture 
All animal procedures were approved by the Marquette 
University Institutional Animal Care and Use Committee. Cortical 
neurons were prepared from Sprague Dawley rat pups (Harlan) and 
transfected as in Blackmore et al. (2010). Briefly, early postnatal (P3–
P5) frontal cortices were placed in ice-cold Hibernate E (Life 
Technologies A12476-01), their meninges removed, minced finely and 
transferred into 10 ml dissociation media for 30 min at 37 °C with 
constant shaking (HibernateE containing 20 U/ml papain (Worthington 
3126) and 2.5 μg/ml DNAse (Sigma D4527)). Cells were then rinsed 
with Hibernate E + 2% SM1, gently triturated three times, rinsed in 
Hibernate E (no SM1), and incubated 30 min at 37 °C with constant 
shaking in 10 ml trypsin solution (Hibernate E containing 0.25% 
trypsin (Invitrogen/Gibco 15,090–046) and 2.5 μg/ml DNAse (Sigma 
D4527)). Cells were pelleted, washed with Hibernate E + 2% SM1, and 
triturated three times in 1.5 ml Hibernate E + 2% SM1 containing 2 μl 
DNAse (Sigma D4527). The suspension settled for 2 min and the 
supernatant was collected; the process was repeated until no cell 
clumps were visible. Collected cells were washed and resuspended in 
6-7 ml Hibernate E, typically yielding 2 million cells/ml. For 
transfection, cortical neurons were pelleted and resuspended to 
2 × 106 cells/ml in Internal Neuronal Buffer (INB) (KCl 135 mM, CaCl2 
0.2 mM, MgCl2 2 mM, HEPES 10 mM, EGTA 5 mM, pH 7.3). 25 μl were 
placed into wells of a 96-well electroporation plate (BTX Harvard 
Apparatus 45–0450) and mixed with 25 μl of INB containing 1 μg EGFP 
plasmid and 4 μg test plasmid. A 350 V, 300 μs pulse was delivered to 
each well by an ECM square wave pulse generator (Harvard Apparatus 
ECM-830) attached to a plate handler (BTX Harvard Apparatus HT-
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200). 100 μl of Hibernate E was added to each well following 
electroporation. For cell culture, 10,000 cells/well were placed in 24-
well plates (Greiner Bio-One 662,160) pre-coated with 100 μg/ml poly-
d-lysine hydrobromide (Sigma P7886) (> 12 h, 37 °C), followed by 
10 μg/ml laminin (Sigma L2020) (> 2 h, 37 °C). For inhibitory 
substrates, 25 μg/ml Chondroitin Sulfate Proteoglycans (Millipore 
CC117) were added to 10 μg/ml laminin and incubated concurrently 
with laminin alone treatments. Cells were maintained at 37 °C, 5% 
CO2 in Enriched Neurobasal (ENB) media, modified from (Meyer-
Franke et al., 1995), consisting of Neurobasal A (Invitrogen 10,888–
022), 50X NeuronCult SM1 Neuronal Supplement (Stemcell 
Technologies 5711), 1 mM sodium pyruvate (Invitrogen 11360-070), 
2 mM GlutaMAX (Invitrogen/Gibco 35050-061), 50 U/ml Penicillin–
Streptomycin (Invitrogen 15070-063), 5 μM Forskolin (Sigma F6886). 
2.3. Sensory cell dissociation, transfection, and culture 
Dorsal root ganglia neurons (DRGs) were isolated from freshly 
euthanized mice and digested with a solution of collagenase 
(0.5 mg/ml, Invitrogen 17105-041) and dispase (10 mg/ml, Invitrogen 
17100) at 37° for 40 min. Cells were brought to single suspension with 
pipette trituration and then pelleted at 80 G for 5 min. The cell pellet 
was resuspended in the P3 Primary Cell Nucleofector kit solution 
(Lonza CC-4461) and approximately 20,000 DRG neurons were 
transfected with 1 μg of EBFP-2A-H2B-mCherry or HHEX-2A-H2B-
mCherry plasmid DNA using the CA-138 program on the 4D-
Nucleofector™ System (Lonza). After transfection 80 ul of warm 
PNGM™ Primary Neuron Growth Medium (Lonza CC-4461) was added 
to each electroporation well. The entire resulting cell solution was 
placed into a single well of a 24-well tissue culture plate (Corning). 
After 72 h, cells were trypsinized, pelleted at 900 G for 3 min, and 
then resuspended in 200 ul of warm media. The cell suspension was 
divided between two wells in a 24-well tissue culture dish. 15 h after 
replating, the cells were fixed and immunostained with a neuronal 
specific tubulin rabbit polyclonal antibody (1:2000, Sigma T2200) 
followed by secondary application of Alexa Fluor® 555 dye (Life 
Technologies A-21430) and Hoechst dye (0.5 μg/ml, Sigma B2261) to 
enable nuclei detection. 
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2.4. Cortical cell culture immunohistochemistry 
Cultures were fixed in 4% paraformaldehyde (Electron 
Microscopy Sciences 15710) for 30 min at room temperature, rinsed 
five times, blocked and permeabilized (PBS, 20% goat serum 
(Invitrogen 16210-064), 0.2% Triton X-100 (G-Biosciences 786-513) 
for 30 min at room temperature, and incubated in primary antibody 
solution (PBS, 10% goat serum, 0.2% Triton X-100, primary 
antibodies: rabbit anti-βIII-tubulin (1:500, Sigma T2200), mouse anti-
Tau-1 (1:1000, Millipore MAB3420), rabbit anti-MAP2 (1:2000, 
Millipore AB5622), mouse anti-HHEX (1:200, Sigma SAB1403914)) 
(overnight, 4 °C). After five washes, cultures were incubated in 
secondary antibody solution containing DAPI nuclear stain (PBS, 10% 
goat serum, 0.2% Triton X-100, 300 nM DAPI, dilactate (molecular 
probes D3571) Secondary antibodies: Alexa Flour 647 goat anti-rabbit 
IgG (1:500, Invitrogen A21245), Alexa Fluor 488 goat anti-mouse IgG 
(1:500, Invitrogen A11001)) for 2 h at room temperature. Plates were 
washed five times, and left in 1 ml PBS for imaging. 
2.5. Cortical and DRG tissue staining 
Adult brains were snap frozen, cryosectioned into 20 μm 
sections, post-fixed in 4% PFA (20 min, room temperature), blocked 
(1 h, room temperature), and incubated in primary antibody solution 
(primary antibodies: anti-HHEX (1:100, Sigma SAB1403914, LSBio 
LSB3077), anti-NeuN (1:100, MAB377A5)) overnight at 4 °C. After five 
washes with PBS, sections were incubated in secondary antibody 
solution (2 h, room temperature), and stained with 300 nM DAPI 
(20 min, room temperature). Slides were washed with PBS three times 
and mounted with Fluoro-gel (Electron Microscopy sciences 1798510). 
CST retrograde labeling was performed on injured animals as in (Wang 
et al., 2015). Briefly, a 0.85 mm deep lesion was made 1 mm to the 
left of the midline between C4/C5. 1 μl CTB-Alexafluor 647 (Life 
Technologies C-34,778) was injected at C4/C5 seven days prior to 
sacrifice and snap freezing. 
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2.6. Imaging and quantification of neurite length 
For neurite outgrowth assays, Cellomics Cell Insight NXT 
(Thermo Scientific) acquired images of 3 channels: nuclei (DAPI), 
neurite staining (βIII-tubulin), and reporter (EGFP), and Cellomics 
Scan v6.4.0 (Thermo Scientific) traced neurites and quantified reporter 
intensity. Average total neurite length was quantified for the 10% of 
cells with greatest EGFP intensity per plate (n > 100 cells per 
treatment). Average neurite length was normalized to mCherry control 
for each plate. Each treatment was tested at least three times; those 
that differed significantly from mCherry control were flagged as hit 
genes (*p < .05 ANOVA with post-hoc Dunnett's). For axon growth 
and differentiation assays, a fluorescent inverted microscope was used 
to identify mCherry + MAP2 + cells as transfected neurons. Axons 
were identified by Tau-1 staining, and hand traced using NIS-Elements 
Basic Research software. Axon length for neurons with an axon and 
percentage of neurons with an axon were quantified for n = 75 cells 
per treatment. Statistical analysis was paired t-test using Graphpad 
Prism Software. 
For DRG neurite outgrowth assays, a Cellomics ArrayScanXTI 
(Thermo Scientific) acquired images in 3 channels: nuclei (Hoechst), 
neurite staining (βIII-tubulin), and reporter (mCherry), and the 
Neuronal Profiling v4.1 algorithm (Thermo Scientific) traced neurites 
and quantified reporter intensity. Cells were considered mCherry + 
when the pixel intensity in the cell reached 2 standard deviations 
above the mean intensity for mCherry in non-transfected control wells. 
Average neurite length was normalized to EBFP-2A-H2B-mCherry for 
each plate. The experiment was repeated three times. Statistical 
analysis was paired t-test using Graphpad Prism Software. 
2.7. Cell survival assay 
Cortical neurons were transfected and cultured as previously 
described, using HHEX as the test gene and an EBFP-2A-mCherry 
reporter in place of EGFP. After one day in culture, 1 μM staurosporine 
toxin (Sigma S5921) was added to a subset of EBFP-2A-mCherry 
wells. The following day media was replaced with either 0.05 μM 
Calcein AM (Life Technologies C3099), or 0.01 μM Yo-Pro-1-Iodide 
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(Life Technologies Y3603), both in PBS and containing 1 μg/ml 
Hoechst 33342 (Molecular Probes H1399), and incubated (30 min, 
37 °C). Cellomics Cell Insight NXT (Thermo Scientific) acquired images 
for three channels: nuclear (Hoechst 33,342), cell survival stain 
(Calcein AM or Yo-Pro), and reporter (EBFP-2A-mCherry); 
compartmental analysis quantified intensities for each channel, and 
data were exported to Excel for analysis. The percentage of surviving 
cells (Hoechst +/Calcein AM +) and the percentage of apoptotic cells 
(Hoechst +/Yo-Pro-1-Iodide +) were quantified in five independent 
experiments. Statistical analysis was by ANOVA with post-hoc 
Dunnett's was performed using Graphpad Prism Software. 
2.8. Western blotting 
Lysates for Western blotting were prepared from HEK293 cells 
that were transfected with either EBFP-2A-H2B-mCherry or HHEX-2A-
H2B-mCherry plasmids according to manufacturer's instructions 
(Lipofectamine 2000, Invitrogen 11668-027). Two days post 
incubation, cells were lysed using 200 μl lysis buffer (150 Mm sodium 
chloride, 1.0% Triton-X 100, 0.5% sodium deoxycholate, 0.1% SDS, 
50 Mm Tris with protease inhibitors according to manufacturer's 
instructions (Roche 5892791001)), and cell debris was removed 
through centrifugation at 4° for 15 min at 21,000 rcf. P3 cortex, adult 
cortex and adult DRGs tissues were collected into 200-500 μl lysis 
buffer, and lysed using a homogenizer (VWR KT885450-0020), 
incubated on ice for 30 min and cell debris was removed through 
centrifugation at 4°. Protein concentration was estimated using the 
BCA method. A portion of the lysate (10–40 μg of protein) was 
fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), 
and the separated proteins were transferred to a PVDF membrane. 
Specific antibodies (Sigma SAB1403914; LSBio LSB3077; 1:1000 
dilution) were used to probe for HHEX protein. Immune complexes 
were detected with suitable secondary antibodies and 
chemiluminescence reagents (ThermoScientific). β-actin primary 
antibody (ab6276, 1:2500 dilution) was used to ensure equal gel 
loading and transfer. 
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3. Results 
3.1. High content screening of cancer related 
transcription factors 
We first used existing datasets to examine the potential overlap 
between TFs implicated in cancer biology with TFs linked to axon 
growth. Using the Gene Ranker tool maintained by the Memorial Sloan 
Kettering Cancer Center, we acquired a list of 1258 genes that are 
strongly correlated with and/or functionally linked to oncogenesis or 
tumor suppression. This list contained 254 TFs, as defined by Gene 
Ontology terms DNA Binding and Regulation of Transcription, DNA 
Template. Of these, 166 TFs are expressed in the adult and/or 
developing cortex according to the Allen Brain Atlas (Supplementary 
Table 1). Intriguingly, these 166 cancer-related TFs included many 
genes that are already known to regulate axon growth, including 9 out 
of 10 factors discussed in a recent review of the transcriptional control 
of axon growth (ATF3, CREB, JUN, KLF4 and -6, NFKB1, SNON, the 
SOXC family, STAT3, and p53/TP53) (Gao et al., 2004, Qiu et al., 
2005, Stegmuller et al., 2006, Gallagher et al., 2007, Seijffers et al., 
2007, Jankowski et al., 2009, Moore et al., 2009, Tedeschi et al., 
2009, Lerch et al., 2014 and Wang et al., 2015).This high degree of 
overlap supports the notion of common transcriptional mechanisms 
that influence growth across diverse cell types, and raised the question 
of whether other cancer-implicated TFs on the list, many of which are 
unstudied in a neuronal context, might also act as regulators of axon 
growth. 
We therefore used an established high content screening 
approach to quantify how cancer-related TFs affected neurite 
outgrowth when expressed in cortical neurons (Moore et al., 2009, 
Blackmore et al., 2010 and Lerch et al., 2014). Sixty-nine cancer-
related TFs were examined. Importantly, this subset was an effectively 
random sample based on availability in pre-made expression libraries 
(Open Biosystems), and not selected by user prioritization. Postnatal 
rat cortical neurons were co-transfected with plasmid DNA encoding 
test genes and a fluorescent reporter plasmid and then cultured on 
laminin substrate. Two days later, automated microscopy 
(ThermoScientific CellInsight Nxt) quantified neurite outgrowth from 
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cells identified as neurons through βIII tubulin immunostaining (Fig. 
1B) and positive for transfection through expression of EGFP reporter 
(Fig. 1C). Each gene was tested in three independent experiments, 
and neurite lengths were normalized to mCherry control 
(Supplementary Table 1). The set of “cancer” genes included JUN, a 
known promoter of neurite growth, as well as KLF4 and KLF6, shown 
previously to inhibit and promote neurite growth, respectively (Moore 
et al., 2009, Blackmore et al., 2010 and Lerch et al., 2014). These 
genes therefore functioned as positive controls. As expected, KLF4 
significantly reduced (73.3% ± 3.7%, p < 0.01) and KLF6 and JUN 
expression significantly increased (125.8% ± 5.6%, 126.2% ± 6.9%, 
p < 0.01) neurite lengths, confirming the screen's ability to detect TF-
evoked changes in neurite length. Notably, in addition to the controls, 
6 candidate genes significantly altered neurite lengths, with 2 acting as 
growth enhancers and 4 as suppressors (Fig. 1E). In summary, nearly 
15% of candidate TFs, selected on the basis of their involvement in 
cellular growth outside the nervous system, displayed an ability to 
modulate neurite outgrowth in primary neurons. 
 
Fig. 1. Phenotypic screening of oncogenic and tumor suppressive transcription factors 
identifies HHEX as an inhibitor of neurite outgrowth. P3 cortical neurons were co-
transfected with EGFP and either mCherry control or test plasmid and cultured on 
laminin substrates for two days. (A–D) Images were acquired through automated 
microscopy (nuclear: DAPI, neuronal: βIII-tubulin, transfection: EGFP). Cells positive 
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for neuron-specific βIII-tubulin and EGFP (arrowheads, B and C) were used for 
subsequent analyses. (E) Bars show the average neurite length in cells expressing 69 
test genes across three replicate experiments (dots), normalized to mCherry control. 
Test genes included KLF4, KLF6, and JUN, all of which showed expected changes in 
neurite length, confirming assay sensitivity. Six additional test genes significantly 
altered neurite length, two positively and four negatively. HHEX (black bar) strongly 
and consistently inhibits neurite outgrowth. *p < .05 ANOVA with post-hoc Dunnett's, 
N > 100 cells in three replicate experiments. Scale bar is 50 μm. 
3.2. HHEX inhibits axonogenesis without affecting 
viability 
The homeodomain factor HHEX emerged from the initial 
screening experiment as one of the most potent and consistent 
inhibitors of neurite outgrowth, and was prioritized for additional 
analysis. To better characterize the effects of HHEX on neuronal 
morphology we performed a time-course experiment with axon-
specific Tau1 antibodies (Fig. 2). Postnatal cortical neurons were 
transfected with either HHEX plasmid DNA or EBFP control, and axon 
formation and length were quantified by hand tracing of Tau1-positive 
neurites. About 35% of control-transfected neurons extended an axon 
(Tau1 + process) within 24 h of plating, and the percent of axon-
bearing neurons increased steadily to a plateau of about 90% by three 
days in vitro (DIV; Fig. 2C). In contrast, within 24 h of plating only 
21% of HHEX-transfected neurons extended a Tau + axon (Fig. 2C), 
and the percent of axon-bearing HHEX-transfected neurons never rose 
above 45%. These data confirm that HHEX expression interferes with 
axonogenesis. 
 
 
Fig. 2. HHEX expression reduces axon formation and elongation. P3 cortical neurons 
were transfected with HHEX-2A-mCherry or EBFP-2A-mCherry control and cultured for 
1 to 4 days in vitro (DIV). (A,B) Tau1 immunohistochemistry (green) identifies axons 
in neurons cultured for three days. Transfected neurons are identified by mCherry 
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fluorescence (arrowheads). Neurons expressing EBFP control extended long axons, 
whereas neurons transfected with HHEX extended no axons or short axons 
(arrowheads, B, inset is HHEX phenotype in higher magnification with βIII tubulin in 
white). (C) Quantification of the percent of neurons with Tau1 + processes shows a 
significant reduction in axon differentiation in HHEX expressing cells at the 3 and 4 day 
timepoint. (D) Quantification of axon length, based only on neurons that possessed a 
Tau1 + process, shows significant reduction in HHEX-expressing neurons compared to 
control at 2 and 3 days in vitro. * p < .05, ** p < .01, paired t-test, N > 40 cells each 
of three replicate experiments. Scale bar is 50 μm. 
To determine whether HHEX also affects the rate of extension of 
existing axons we hand-traced Tau1 + processes at 2 and 3DIV; 
quantification at 4DIV was prevented by overgrowth of axons that 
prevented clear discrimination of the cell of origin. At 2DIV, axon 
length in HHEX-expressing neurons was 44% lower than control 
(161 μm ± 26.7 μm SEM versus 284.4 μm ± 36.8 μm SEM; p < 0.01, 
paired T-test) (Fig. 2D). Over the next 24 h, control neurons increased 
average axon lengths to 653.3 μm ± 76.4 μm SEM (an average net 
addition of 368.9 μm), while HHEX-expressing neurons increased to 
357.5 μm ± 40.0 μm SEM, (an average net addition of 195.5 μm). 
These data indicate that HHEX expression does not simply delay axon 
formation, but also slow net axon growth between 2DIV and 3DIV. 
Consistent with this, a time-course analysis using automated tracing 
showed that HHEX and EBFP-transfected neurons displayed similar 
neurite lengths at the one day time-point, but that the subsequent 
daily increases in neurite length were more than 50% lower in HHEX-
expressing neurons (Supplemental Fig. 1). Thus HHEX expression also 
appears to decrease the rate of elongation of extant processes. 
We next considered the possibility that the effect of HHEX on 
axon growth could be secondary to a reduction in cell viability. This 
issue is particularly important given the involvement of HHEX in cell 
proliferation in non-neuronal cells, and findings that modulation of cell 
cycle regulators can induce apoptosis in post-mitotic neurons 
(Kranenburg et al., 1996 and Nguyen et al., 2002; Greene et al., 
2004 and Hoglinger et al., 2007). Cortical neurons were transfected 
with HHEX or EBFP control plasmid carrying mCherry reporter, and a 
third group of EBFP-transfected neurons were treated with the toxin 
staurosporine as a positive control for reduced viability. After two days 
in culture, a time point at which effects on axon growth are robust 
(Fig. 2), Cellomics image analysis quantified the percent of transfected 
(mCherry +) neurons that stained positively for Yo-Pro-1-Iodide or 
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Calcein AM, indicators of apoptotic and live cells respectively (Fig. 3A–
F). As expected, staurosporine elevated Yo-Pro and decreased Calcein 
signal, confirming the sensitivity of the assay. In contrast, HHEX-
transfected neurons showed neither elevated Yo-Pro signal nor 
decreased Calcein compared to EBFP control (Fig. 3G). Combined, 
these experiments confirm that HHEX overexpression interferes with 
axonogenesis and slows axon elongation, without any corresponding 
decrease in cell viability. 
 
 
Fig. 3. Cell viability is unaffected by HHEX overexpression. P3–P5 cortical neurons 
were transfected with HHEX or EBFP control along with mCherry reporter and cultured 
for two days. Staurosporine toxin was added to a subset of EBFP-transfected cells as a 
positive control for detection of altered viability. Cells were visualized with DAPI (A,D), 
mCherry reporter (B,E), and live cell indicator calcein (C) or the dead cell indicator Yo-
Pro (F). Arrowheads indicate nuclei (DAPI, A and D) associated with transfected cells 
(mCherry positive, B and E) that are alive (positive for calcein, C, or negative for Yo-
Pro, F). (G) Quantification based on cellomics automated microscopy shows that 
staurosporine significantly reduces the percent of calcein-positive cells and increases 
the percent of Yo-Pro positive cells, whereas HHEX expression had no effect. 
**p < .01, n.s. p > .05, ANOVA with post-hoc Dunnett's. N > 200 transfected cells 
from each of six replicate experiments. Scale bar is 50 μm. 
3.3. Mutation analysis suggests transcriptional 
repression as relevant mechanism 
Wild type HHEX protein is comprised of a DNA binding domain 
flanked by an N-terminal domain that mediates transcriptional 
repression (Tanaka et al., 1999), and a C-terminal domain that 
mediates transcriptional activation (Kasamatsu et al., 2004 and Soufi 
and Jayaraman, 2008). Thus, depending on cellular context, HHEX can 
either activate or repress target genes, raising the question of which 
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activity is relevant to the suppression of axon growth. We therefore 
created HHEX truncation mutants that lacked either the activation 
domain (HHEX-∆C) or the repression domain (HHEX-∆N), and tested 
their effects on neurite outgrowth in cortical neurons, as described 
above (Fig. 4). All constructs included a 2A-H2B-mCherry fluorescent 
reporter, allowing specific identification of transfected cells. In 
addition, the fluorescent reporter, as well as direct 
immunohistochemistry for HHEX protein, confirmed effective 
expression of all constructs. Removal of the repression domain, but 
not the activation domain, completely abolished growth inhibition, 
suggesting that transcriptional repression may be necessary for 
HHEX's effects on neurite growth (Fig. 4B). Moreover, a chimeric 
construct in which the endogenous HHEX N-terminal domain was 
replaced by an alternative Engrailed repression domain phenocopied 
the full length HHEX repression of neurite outgrowth. This result 
indicates that transcriptional repression per se, as opposed to a non-
transcriptional activity localized to the N-terminal HHEX sequence, 
causes inhibition of axon growth. Combined, these data identify 
transcriptional repression domains as both necessary and sufficient for 
HHEX's inhibition of neurite growth, and suggest a model in which 
HHEX normally inhibits gene targets that are needed for efficient 
neurite extension. 
 
Fig. 4. A transcriptional repression domain is both necessary and sufficient for HHEX's 
inhibition of neurite growth. Domain-deletion and domain-swapped HHEX mutants, 
shown schematically in (A), or EBFP control plasmids were overexpressed in early 
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postnatal cortical neurons and cultured for two days. (B) Neurite outgrowth was 
quantified by automated microscopy. HHEX-ΔC inhibits neurite growth similarly to full 
length HHEX, showing that the C-terminal activation domain is dispensable for growth 
inhibition. In contrast, removal of the N-terminal domain abolished growth inhibition. 
Finally, Engrailed-HHEX also inhibits neurite growth. These experiments suggest that 
HHEX likely inhibits neurite outgrowth through a mechanism of transcriptional 
repression. **p < .01, ANOVA with post-hoc Dunnett's. N > 150 transfected cells in 
each of five replicate experiments. 
3.4. HHEX is expressed in adult CNS neurons 
Although CNS expression is suggested by in situ data from the 
Allen Brain Atlas, HHEX has been previously described only in 
hematopoietic lineages and in endoderm-derived tissues such as 
thyroid, pancreas, liver, and lung (Bogue et al., 2000 and Soufi and 
Jayaraman, 2008). To establish HHEX's relevance to axon growth it is 
therefore essential to examine its endogenous pattern of expression in 
the nervous system. We first validated two anti-HHEX antibodies using 
HHEX-transfected HEK293 cells. As expected, control-transfected 293 
cells displayed no HHEX expression by immunohistochemistry or 
Western blotting, whereas HHEX-transfected cells showed clear signal 
with both antibodies (Supplemental Fig. 2). These data demonstrate 
the specificity of the anti-HHEX antibodies in both 
immunohistochemistry and Western blotting experiments. 
We first examined HHEX expression in the adult murine cortex 
by Western blot, and observed a clear ~ 42 kD band at the same 
position as overexpressed full-length HHEX (Fig. 5A). These data 
confirm expression of HHEX protein in the adult cortex. In contrast, 
cortex from postnatal day 3 (P3), the age at which cells were prepared 
for neurite outgrowth assays, did not show detectable expression of 
HHEX by Western blotting. Consistent with this, immunohistochemistry 
on cultured P3 cortical neurons detected no endogenous HHEX in cells 
transfected with EBFP control plasmid, but did confirm the presence of 
HHEX protein in cells transfected with HHEX plasmid (Fig. 5B–E). 
Combined, these data demonstrate expression of HHEX in cortical 
tissue of adult but not early postnatal age. 
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Fig. 5. HHEX is widely expressed in adult, but not neonatal, CNS neurons. (A) Western 
blotting detects HHEX in 293 cells transfected with HHEX plasmid, but not in EBFP-
transfected control cells, confirming antibody specificity. HHEX protein is also detected 
in adult murine cortex, but not in postnatal tissue at the age used to prepare neurons 
for cell culture. (B–E) P3 cortical neurons were transfected with EBFP-2A-H2B-mCherry 
control plasmid or HHEX-2A-H2B-mCherry and cultured for two days. mCherry 
expression (red, B,D) identifies transfected cells, and immunohistochemistry for βIII 
tubulin (white) identifies neurons. Immunohistochemistry detects HHEX in HHEX-
transfected neurons (green, arrow, E), but not in control transfected neurons (arrow, 
C). Adult hippocampus (F,G) or cortex (H–K) was stained with DAPI (nuclei, H), anti-
NeuN antibody (J,G) and anti-HHEX antibody (F,I). In both brain regions, endogenous 
HHEX expression co-localized with NeuN confirming widespread expression of HHEX in 
neuronal nuclei in the CNS. Scale bars are 50 μm (E), 500 μm (G), and 20 μm (K). 
To further explore the relationship between HHEX protein 
expression and neurite length we visualized HHEX protein in HHEX-
transfected or EBFP-transfected control neurons while simultaneously 
measuring neurite lengths. Quantification of the intensity of HHEX 
immunohistochemistry signal in HHEX-transfected neurons showed a 
range of intensities above the background level in control cells, 
indicating variable levels of HHEX protein expression (Supplemental 
Fig. 3). Analysis of average neurite lengths, binned according to 
increasing levels of HHEX protein, confirmed a significant reduction in 
neurite length in neurons with elevated HHEX expression. Neurite 
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lengths were significantly reduced in neurons with relatively modest 
HHEX expression, such that neurons within the second quintile of 
HHEX intensity were 71.2% of control length (p < .05, ANOVA with 
Dunnet's post-hoc), with neurons in the brightest HHEX quintile 
averaging 56.1% of control. These data confirm with direct detection 
that increased expression of HHEX protein in postnatal cortical neurons 
reduces neurite outgrowth. 
To determine whether HHEX is expressed specifically in neurons 
in the adult brain, as opposed to other cell types, we examined murine 
brain sections by immunohistochemistry, using NeuN as a neuronal 
marker. Intriguingly, we observed a striking and complete overlap 
between HHEX and NeuN reactivity (Fig. 5F–K). HHEX was detected in 
all NeuN + nuclei examined in the forebrain, midbrain and hindbrain 
and was not detected in adjacent NeuN-negative nuclei, indicating 
expression that is widespread and highly specific to neurons. To 
confirm these findings we repeated the experiment with a second 
antibody against HHEX that was raised against a distinct epitope, with 
identical results (Supplemental Fig. 4). To assess HHEX expression in 
CNS neurons that are responding to axotomy, we performed spinal 
transections and injected retrograde tracers to the injury site to 
identify axotomized corticospinal tract (CST) neurons. Two weeks 
post-injury, HHEX was readily detectable in all injured CST neurons, 
and the intensity of staining appeared neither elevated nor decreased 
(Fig. 6). These data show expression of HHEX protein in the adult CNS 
neurons, including CST neurons after spinal injury. 
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Fig. 6. HHEX is expressed in corticospinal tract (CST) neurons after axotomy. CST 
axons were severed in the cervical spinal cord of adult mice and the retrograde tracer 
cholera toxin B (CTB) conjugated to Alexafluor 647 (CTB-647) injected to the injury 
site. Two weeks later cortical sections were prepared and immunohistochemistry for 
HHEX performed. A and D show HHEX expression, B and E show retrogradely 
identified CST neurons, and C and F show the overlap. Arrows indicate CST neurons 
with clear HHEX signal. Scale bars are 100 μm (C) and 10 μm (F). 
Axon growth in the adult CNS is constrained in part by inhibitory 
substrates such as chondroitin sulfate proteoglycans (CSPGs) (Carulli 
et al., 2005). We therefore explored potential interactions between 
CSPG substrates and HHEX expression by culturing neurons on 
substrates of laminin (10 μg/ml) or a mixture of laminin and CSPGs 
(10 μg/ml laminin, 25 μg/ml CSPGs) and performing 
immunohistochemistry for HHEX. HHEX was detectable on neither 
substrate, and automated microscopy confirmed similar levels of HHEX 
signal on laminin and CSPG substrates. As a positive control the 
immunohistochemistry, HHEX was readily detectable in HHEX-
transfected cells. (Fig. 7A–E). These data indicate that HHEX 
expression is insensitive to CSPG exposure. 
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Fig. 7. HHEX inhibits neurite outgrowth independently of chondroitin sulfate 
proteoglycan signaling. Cortical neurons were transfected with EBFP control plasmid or 
HHEX and cultured for three days on laminin or a laminin/CSPG mixture. Automated 
image analysis quantified the intensity of HHEX immunohistochemistry and the length 
of neurites. (A–D) HHEX protein was not detected EBFP-transfected neurons on 
laminin (inset, A) or CSPG (inset, B) substrate, but was readily visible in HHEX-
transfected neurons (insets, C,D). (E) Quantification of HHEX immunohistochemistry 
performed on untransfected neurons shows no significant change in HHEX expression 
as a result of exposure to CSPG substrates (p > .05, paired t-test, N > 2000 neurons). 
(F) Neurite lengths were significantly reduced on CSPG substrates. On both laminin 
and CSPG substrates, transfection with HHEX plasmids decreased neurite lengths 
compared to EBFP control. **p < .01, two way ANOVA, N > 100. Scale bar is 10 μm. 
Next, to test whether HHEX-mediated inhibition of neurite 
outgrowth was affected by CSPG substrates, neurons were transfected 
with HHEX or control plasmid and cultured on laminin or CSPG 
substrates. As expected, neurite outgrowth by control-transfected 
neurons was reduced on CSPG substrates (69.9% shorter than on 
laminin) (Fig. 7F). On laminin substrate, HHEX expression caused a 
39% reduction in neurite length compared to mCherry control. On 
CSPG substrates, HHEX also reduced neurite lengths, and did so to a 
degree that was proportional to the effect on laminin (35% shorter 
than control-transfected neurons on CSPGs). Combined with the 
insensitivity of HHEX expression to CSPG, these data suggest that the 
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molecular mechanisms that mediate growth inhibition by HHEX 
function independently of those triggered by CSPG substrates. 
3.5. HHEX expression and function in peripheral 
neurons 
We next examined HHEX expression in peripheral neurons of the 
dorsal root ganglia (DRG), which possess a generally higher 
regenerative capacity than CNS neurons. Immunohistochemistry for 
HHEX showed very dim signal in sections of adult DRG; as a positive 
control, adult cortical tissue processed in parallel and visualized with 
identical acquisition parameters showed bright HHEX signal (Fig. 8A, 
B). Similarly, Western blotting in DRG tissue detected very faint size-
shifted bands, but no HHEX protein in a position corresponding to 
overexpressed HHEX protein or to protein detected in adult cortex (Fig. 
8C). Adult DRG neurons are known to extend lengthy processes when 
placed in culture, and this response requires extensive transcriptional 
changes that occur in the days after plating. We therefore performed 
immunohistochemistry for HHEX in DRG neurons that were transfected 
with EBFP-2A-H2B-mCherry control or HHEX-2A-H2B-mCherry and 
maintained in culture for three days (Fig. 8D–G). HHEX protein was 
not detected in control-transfected DRG neurons, but was readily 
detectable in HHEX-transfected cells (Fig. 8D–G). Combined, these 
data suggest that unlike CNS neurons, regeneration-competent PNS 
neurons do not express detectable amounts of HHEX protein in neither 
the uninjured state, nor when engaged in injury-triggered axon 
growth. 
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Fig. 8. HHEX is more abundant in the central than in the peripheral nervous system. 
(A,B) Dorsal root ganglia (DRG, A) and cortex (B) were stained in parallel with anti-
HHEX antibodies. HHEX is readily detectable in cortex but, using identical acquisition 
parameters, was not detected in DRG tissue. (C) Western blotting detects HHEX 
protein in HHEX-transfected 293 cells and adult cortex, but detects only faint and size-
shifted protein bands in DRG tissue. (D–G) Adult DRG neurons were transfected with 
control EBFP-2A-H2B-mCherry (D,E) or HHEX-2A-H2B-mCherry (F,G), cultured on 
laminin substrate for four days, followed by immunohistochemistry for βIII tubulin 
(white) and HHEX (green, E,G). HHEX was not detected in EBFP-transfected DRG 
neurons, but was readily detected in HHEX-transfected cells. Scale bars are 100 μm 
(A) and 50 μm (D–G). 
We therefore tested the effects of elevating full-length HHEX 
expression in DRG neurons. Cultured DRG neurons were transfected 
with plasmids encoding HHEX or EBFP, maintained for the three days, 
and then replated to remove existing neurites. The amount of neurite 
growth generated in the subsequent 24 h was then quantified. This 
paradigm avoids technical problems associated with excessive axon 
growth by DRG neurons during the lag between plasmid transfection 
and protein function. Immunohistochemistry confirmed exogenous 
HHEX expression (Fig. 8F, G). Compared to EBFP control, HHEX 
expression significantly reduced the number of neurites by 2-fold and 
the total length of neurites produced by DRG neurons (Fig. 9). 
Combined, these data demonstrate that ectopic expression of full-
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length HHEX, normally absent in PNS neurons, is sufficient to reduce 
the regenerative capacity of DRG neurons. 
 
Fig. 9. HHEX overexpression reduces DRG neurite outgrowth. Adult DRG neurons were 
transfected with EBFP-2A-H2B-mCherry (A,C) or HHEX-2A-H2B-mCherry (B,D), 
maintained for three days, re-plated to remove existing neurites, and then maintained 
for one additional day. Neuron-specific tubulin (green, A,B) identifies neurites and 
mCherry (arrowheads, A,B) identifies transfected cells. (C,D) Neurite outgrowth was 
quantified with the Neuronal Profiling Algorithm on a Cellomics ArrayScanXTI High 
Content Analysis microscope (ThermoFisher) after imaging and mask creation. Cell 
bodies are indicated by blue circles, and neurites are shown in green or red. (E) 
Neurite outgrowth was normalized to the average total neurite length for EBFP-2A-
H2B-mCherry transfected DRGs. N > 100 cells in three replicate experiments, 
**p < 0.001, paired t-test. Scale bar is 150 μm. 
4. Discussion 
This study used a screening approach to identify the 
homeodomain factor HHEX, previously studied as a tumor suppressor 
in hematopoietic and endodermal lineages, as a potent suppressor of 
axon growth when overexpressed in CNS neurons. Our data suggest 
that HHEX may act through a mechanism of transcriptional repression 
to reduce both axon initiation and extension, without negatively 
affecting cell viability. Moreover, HHEX is endogenously expressed in 
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the nuclei of CNS neurons, including CST neurons after axotomy. In 
contrast, peripheral DRG neurons express much lower levels of HHEX, 
and forced expression of HHEX reduces DRG axon growth. Combined, 
the phenotypic effects and pattern of expression support the 
hypothesis that transcriptional repression by HHEX may limit axon 
growth in CNS neurons. 
4.1. Transcriptional inhibition of axon growth 
In contrast to HHEX, the majority of TFs that have previously 
been linked to axon growth appear to play pro-regenerative roles, 
likely by coordinating the production of multiple growth-associated 
proteins. Prominent examples include JUN, ATF3, KLF7, SOX11, 
STAT3, and CREB, all of which are active in neurons that mount 
successful axon regeneration but are missing or inactive in non-
regenerating cell types (Gao et al., 2004 and Qiu et al., 2005; Seijffers 
et al., 2007, Jankowski et al., 2009, Blackmore et al., 2012 and Lerch 
et al., 2014). Accordingly, we and the others have pursued forced 
expression of these TFs as a strategy to enhance axon growth (Qiu et 
al., 2005, Seijffers et al., 2007, Jankowski et al., 2009, Blackmore et 
al., 2012, Lerch et al., 2014 and Wang et al., 2015). It is well 
appreciated, however, that regenerative ability can also be held in 
check by the presence of cell-intrinsic factors that limit growth 
potential. Thus, at the level of gene transcription, it may be necessary 
to complement the overexpression approach by neutralizing TFs that 
repress transcription by occupying pro-regenerative loci. The identity 
of such growth-inhibitory TFs, however, remains unclear. Members of 
the KLF family, notably KLF4, are likely candidates because they are 
expressed in poorly-regenerating CNS neurons and contribute to their 
low regenerative capacity (Moore et al., 2009). Whether KLF4 acts as 
a transcriptional repressor of pro-regenerative genes, as opposed to 
alternative mechanisms such as activation of growth inhibitory genes, 
has not been established. 
In this context it is significant that the functional domain 
analyses suggest that HHEX inhibits axon growth through a 
mechanism of transcriptional repression. Although HHEX is known to 
be capable of either activating or repressing target genes, the domain 
deletion experiments showed that a known activation domain is 
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dispensable, and a known repression domain essential, for inhibition of 
neurite outgrowth. In addition, evidence that the Engrailed repression 
domain can effectively substitute for the endogenous HHEX repression 
domain makes it likely that transcriptional repression, and not an 
alternative function specific to the HHEX N-terminal sequence, drives 
inhibition of neurite growth. Direct assays of transcriptional activity 
(e.g. luciferase assays with promoter mutations/deletion) are needed 
to confirm HHEX's transcriptional mode of activity, but the 
experiments reported here support a working model in which HHEX 
transcriptionally represses gene products needed for efficient axon 
growth. 
HHEX is relatively unstudied in the nervous system, but well 
characterized in other systems. HHEX functions as an essential 
regulator of vertebrate development, controlling hematopoietic and 
vascular system formation as well as formation of the vertebrate body 
axis early in development (Soufi and Jayaraman, 2008). HHEX is also 
essential for the formation and maintenance of organs derived from 
the foregut endoderm such as thyroid, liver and lung (Bogue et al., 
2000). HHEX knockout animals die embryonically around day 12 and 
show anterior truncation including a lack of forebrain tissue, but this 
defect has been interpreted as secondary to defects in the anterior 
visceral endoderm signaling center (Martinez-Barbera et al., 
2000 and Martinez Barbera et al., 2000). 
In adult mammals, we find that full length HHEX is widely 
expressed in neurons throughout the central nervous system, with 
expression localized to neuronal nuclei. Consistent with a role for HHEX 
in axon growth inhibition, we observe that CST neurons, which are 
generally refractory to regenerative axon growth, display HHEX 
expression after spinal injury. In contrast, HHEX appears to be much 
less abundant in early postnatal cortical neurons and in DRG neurons, 
both constitutively and during injury-triggered axon growth. When full 
length HHEX is overexpressed in early postnatal cortical neurons or 
DRG neurons, both of which are innately regeneration competent, we 
observe defects in both axon formation and extension. 
Immunohistochemistry showed that significant reductions in neurite 
length occurred in neurons with relatively dim immunohistochemistry 
HHEX signal. Although comparison between immunohistochemistry 
experiments must be made cautiously, it is notable that the intensity 
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of HHEX signal that produced significant reductions in neurite length in 
cultured neurons appeared comparable to or dimmer than the intensity 
of endogenous HHEX in the adult brain. Combined, these data are 
consistent with the notion that endogenous HHEX expression in adult 
neurons may restrict axon growth. 
The identity of HHEX target genes in neurons remains unclear. 
In various proliferative cell types, a number of genes have been shown 
to change in expression upon HHEX overexpression or knockdown, 
including ESM1, VEGF, SST, KIT, and cyclin dependent kinases and 
associated inhibitors (Noy et al., 2010, Shields et al., 2014, Zhang et 
al., 2014 and Jackson et al., 2015). In the case of ESM1, VEGFR, and 
SST direct binding of HHEX to promoter sites has been demonstrated, 
whereas other gene targets may be direct or indirect (Cong et al., 
2006, Noy et al., 2010 and Zhang et al., 2014). In either case, the link 
between these known targets and the suppression of axon growth is 
not obvious. Intriguingly, HHEX has also been shown to inhibit the 
activity of JUN, a well-studied transcriptional promoter of axon growth 
that we confirmed here to increase neurite length (Schaefer et al., 
2001, Raivich et al., 2004 and Lerch et al., 2014). HHEX was also 
recently shown to negatively regulate the activity of MYC, a TF 
implicated in cellular growth and proliferation, and very recently linked 
to axon regeneration in the optic system (Belin et al., 2015 and Marfil 
et al., 2015). Determining direct and indirect gene targets of HHEX in 
neurons, and clarifying the potential interactions of HHEX with JUN 
and/or MYC in the context of axon growth, represents important 
directions for future research. 
4.2. Oncogenes and tumor suppressors as regulators of 
axon growth 
The general notion that intracellular factors implicated in cancer 
biology could regulate axon growth has been previously proposed 
(Park et al., 2008). Axon growth may depend on catabolic processes 
and cytoskeletal dynamics that contribute to cell proliferation and 
motility, much like what is observed in cancerous cells. Conversely, 
tumor suppressive molecules are in place to prevent aberrant growth 
upon maturation. Since many of these genes are expressed in post-
mitotic neurons, it raises a possibility that the tumor suppressor genes 
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may inhibit axonal growth and contribute to the reduced regenerative 
capacity observed in mature CNS neurons. In line with this, the proto-
oncogene JUN drives regenerative axon growth (Raivich et al., 
2004 and Lerch et al., 2014) whereas the tumor suppressor KLF4 
restricts axon growth (Moore et al., 2009). 
We therefore undertook a systematic evaluation of this idea by 
selecting factors based on their tumor suppressor/oncogenic properties 
and examining their effects on neurite growth. Approximately 13% 
about 2% (8/428) in a previous screen using similar techniques but 
which focused on genes that are developmentally regulated 
(Blackmore et al., 2010). This relatively high hit rate corroborates the 
concept that mechanisms driving cellular growth and motility are 
conserved across cell types. Intriguingly, the two TFs that emerged as 
growth promoting in the screen (E2F1 and YAP1) are generally 
considered oncogenic (Alonso et al., 2008 and Liu et al., 2010a), 
whereas the four growth-suppressors (HHEX, PITX1, RBM14, and 
ZBTB16) have been described as tumor suppressive (Kolfschoten et 
al., 2005, Kang et al., 2008, Soufi and Jayaraman, 2008 and Suliman 
et al., 2012). Although it should be noted that factors cannot always 
be cleanly classified due to conflicting findings in different cell types 
(George et al., 2003), the screen results support an overall correlation 
between oncogenesis and axon growth and tumor suppression with 
growth inhibition. Thus further study of factors implicated in cancer 
biology may be a productive means to identify new regulators of axon 
growth. 
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The following are the supplementary data related to this 
article. 
 
Supplemental Fig. 1. Time course analysis shows HHEX to decrease neurite 
extension two and three days after transfection. P3 cortical neurons were co-
transfected with EGFP and either mCherry control or HHEX plasmid and cultured on 
laminin substrates. Cells were fixed 1, 2, or 3 days after plating, stained for neuron-
specific βIII-tubulin, and total neurite outgrowth of transfected (EGFP +) neurons was 
quantified by automated microscopy. After a one-day period of similar outgrowth, 
HHEX-transfected neurons showed a reduction in neurite growth on each of the 
following two days. **p < .01, Paired t-test, N > 100 cells in each treatment at each 
time point. 
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Supplemental Fig. 2. Immunohistochemistry and Western blotting confirms HHEX 
antibody specificity in HEK293 cells. HEK293 cells (A–H) were transfected with either 
EBFP-2A-H2B-mCherry or HHEX-2A-H2B-mCherry and stained with DAPI (nuclei, A 
and B), anti-NeuN antibodies (C,D), and two anti-HHEX antibodies (E–H). HHEX 
expression is detected only in cells transfected with HHEX-2A-H2B-mCherry (green, 
F,H). (I) Western blotting with two independent antibodies detects HHEX protein in 
HHEX-transfected 293 cells, but not EBFP-transfected controls. These results confirm 
antibody specificity. Scale bar is 100 μm. 
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Supplemental Fig. 3. Quantitative analysis of the relationship between neurite length 
and level of forced HHEX protein expression. Cortical neurons were transfected with 
EBFP control plasmid or HHEX and maintained in culture for three days on laminin 
substrates. Immunohistochemistry for βIII-tubulin and HHEX protein was performed 
and cells were analyzed by automated microscopy (Cellomics). (A) Each dot 
represents the average HHEX pixel values for an individual neuron. Values within three 
standard deviations of the mean of EBFP-transfected cells were defined as 
background. As expected, HHEX overexpression resulted in numerous cells with HHEX 
signal above background. (B) The intensity of detection of overexpressed HHEX was 
divided into quintiles, and the average neurite length of neurons falling within each 
quintile was calculated. Significant reductions in neurite length were apparent in 
quintiles 2 to 5. p < .01, ANOVA with post-hoc Dunnet's compared to EBFP-transfected 
neurons. More than 10,000 total cells were analyzed. 
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Supplemental Fig. 4. Immunohistochemistry with alternative anti-HHEX antibody 
confirms neuronal CNS expression. Adult mouse hippocampus (A–D) or frontal cortex 
(E–F) was stained with DAPI (nuclei, A and E), anti-NeuN antibodies (B,F), and anti-
HHEX antibodies raised in rabbit and directed against the homeodomain region (C,G). 
In both hippocampus and cortex, NeuN and HHEX completely colocalized, such that 
HHEX was observed on only in NeuN + nuclei, and all NeuN + nuclei observed also 
expressed HHEX. Scale bars are 100 μm (A–D) and 50 μm (E–H). 
 
Supplemental Table 1.   
The full set of candidate genes identified as tumor suppressive or 
oncogenic and with predicted expression in murine cortex, along with 
effects on normalized neurite outgrowth in three replicate 
experiments. 
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CREB1 Human BC010636,BC010636.1,BE780987,BE780987.1108.992 04.841 81.1292
CTNNB1 Human BC058926,BC058926.1,BU160288,BU160288.1105.565 80.1845 91.6799
E2F1 Human BC058902,BC058902.1,BQ226507,BQ226507.1148.574 05.063 123.16
E2F3 Human BC016847,BC016847.1,BE887804,BE887804.1123.3 3 96.3444 124.7 1
EGR2 Human BC035625,BC035625.1,BI772084,BI772084.1103. 1 31.969 101.582
ELK1 Human BC056150,BC056150.1,BU508792,BU508792.197.7988 02.611 84.0465
ELK4 Human BC063676,BC063676.1,BG024773,BG024773.1101.113 81.9492 77.1691
ERG Human BC040168,BC040168.1,BQ212133,BQ212133.1113.99 71.2539 82.676
ETS2 Human BC017040,BC017040.1,BE870548,BE870548.1100.695 92.7666 77.5331
ETV6 Human BC043399,BC043399.1,BQ430842,BQ430842.1108.491 05.009 106.514
FOSB Human BC036724,BC036724.1,BI907257,BI907257.1100.56 27.844 121.2 4
FOSL1 Human BC016648,BC016648.1,BE898056,BE898056.1120.412 06.572 101.179
HHEX Human BC050638,BC050638.1,BU162190,BU162190.175.7829 66.2395 64.0388
HMGA1 Human BC063434,BC063434.1,BI862491,BI862491.197.179 04.142 90.3558
HOXA5 Human BC013682,BC013682.1,BF036548,BF036548.195. 945 88.1378 91.53 5
KLF4 Human BC029923,BC029923.1,BI259913,BI259913.180.0385 72.4 58 67.
MAFB Human BC028098,BC028098.1,BI916207,BI916207.1115. 8 02.236 98.5559
MAFF Human BC015037,BC015037.1,BE896784,BE896784.1104.928 77.4 51 85.7434
MAX Human BC013669,BC013669.1,BF345380,BF345380.1108. 17 14.89 111.951
MYC Human BC000917,BC000917.2,BE018476,BE018476.1,BE302087,BE302087.1125.409 110.345 106.459
NFKB1 Human BC051765,BC051765.1,BQ962865,BQ962865.187.6738 95.4123 100.9 3
NR4A1 Human BC016147,BC016147.1,BE894720,BE894720.192.2057 106.66 102.085
PITX1 Human BC003685,BC003685.1,BE542190,BE542190.165.5413 73.5991 81.41 1
PPARG Human BC006811,BC006811.1,BE540092,BE540092.183.5 22 88.893 93.8769
RB1 Human BC039060,BC039060.1,BI335137,BI335137.188.8822 96. 32 91.7567
RELA Human BC110830,BC110830.1,BU180728,BU180728.196.5207 92.1225 89.7509
ZBTB16 Human BC026902,BC026902.1,BG914153,BG914153.178.1837 91.355 79.4925
ZFHX3 Human BC029653,BC029653.1,BI224235,BI224235.1118.5 6 92.0885 87.93
ATF3 Mouse BC019946, BC019946.1, BF136102, BF136102.191.0746 87.146 93.9131
BCL11A Mouse AW228991, AW228991.1, AW230045, AW230045.1, BC051418, BC051418.195.193 85.0155 108.192
BCL6 Mouse BC052315, BC052315.1, BQ713052, BQ713052.187.4443 95.185 105.794
CDX1 Mouse BC019986, BC019986.1, BF582917, BF582917.198.4177 12.563 05.3 2
CSRNP1 Mouse BC029720, BC029720.1, BI081828, BI081828.110 .386 99.3558 93.814
CUX1 Mouse BC054370, BC054370.1, BI739304, BI739304.1103.248 87.3118 111.604
DACH1 Mouse BC078644, BC078644.1, BU516638, BU516638.196.5486 97.0682 135.471
DDIT3 Mouse BC013718, BC013718.1, BF137987, BF137987.181.4993 86.1424 3.9582
DDX5 Mouse BC009142, BC009142.1, BE532899, BE532899.111 .042 27.306 109.262
DNMT1 Mouse BC022927, BC022927.1, BF166859, BF166859.197.1934 96.9966 106.933
E2F4 Mouse BC027030, BC027030.1, BI737431, BI737431.1111.296 87.4949 125.78
E2F5 Mouse BC003220, BC003220.1, BE306892, BE306892.197.8358 85.8922 0.8452
E2F6 Mouse BC037656, BC037656.1, BI730404, BI730404.11 1.83 96.8003 114.166
EPAS1 Mouse BC057870, BC057870.1, BI154965, BI154965.185.4695 99.3765 105.823
FOS Mouse AW209146, AW209146.1, AW209393, AW209393.1, BC029814, BC029814.1119.898 113.454 119.017
FOXO3 Mouse BC019532, BC019532.1, BF234887, BF234887.199.6987 03.514 123.7 1
JDP2 Mouse BC019780, BC019780.1, BF134255, BF134255.1112.592 14.087 104.06
JUN Mouse BC002081, BC002081.1, BE283254, BE283254.1119.206 22.751 122.292
JUNB Mouse BC003790, BC003790.1, BE377426, BE377426.192.6273 99.3754 95.9246
JUND Mouse BC023211, BC023211.1, BI256977, BI256977.199.2178 89.2331 105.554
KLF6 Mouse BC020042, BC020042.1, BF138782, BF138782.1115.306 34.204 1 8.147
MAF Mouse BC034073, BC034073.1, BC041683, BC041683.1, BF686992, BF686992.198.3448 89.2782 99.1297
MAFG Mouse BC052633, BC052633.1, BQ713525, BQ713525.199.658 90.3139 97.3636
MAFK Mouse BC014295, BC014295.1, BF539438, BF539438.196.9112 80.9943 8 .76 4
MEF2C Mouse BC037731, BC037731.1, BC057650, BC057650.1, BG288516, BG288516.1104.762 06.441 125.259
MEN1 Mouse BC036287, BC036287.1, BF540354, BF540354.167.7399 06.035 113.425
MXD1 Mouse BC023792, BC023792.1, BI690875, BI690875.199.0813 98.8208 91.3152
ONECUT1 Mouse BC024053, BC024053.1, BI218879, BI218879.1102.294 00.46 100.468
PML Mouse BC020990, BC020990.1, BF537194, BF537194.197.1848 96.434 7.371
PRDM2 Mouse BC043456, BC043456.1, BI112747, BI112747.187.2876 97.0454 85.5396
RARG Mouse AW762114, AW762114.1, BC012923, BC012923.1108.896 91.8687 102.873
RBM14 Mouse AW761991, AW761991.1, BC010294, BC010294.168.4 18 65.5453 85.6647
RORA Mouse BC003757, BC003757.1, BE375733, BE375733.188.5028 97.8821 9 .2346
SKIL Mouse BC024908, BC024908.1, BE534905, BE534905.199.6095 90.7946 106.635
STAT3 Mouse BC019168, BC019168.1, BG873513, BG873513.11 0.42 10.133 98.1421
TCEB3 Mouse BC049885, BC049885.1, BI854885, BI854885.194.5775 04.1 8 105.099
TCF4 Mouse BC014293, BC014293.1, BF142289, BF142289.193.3698 22.907 110.908
THRB Mouse BC042730, BC042730.1, BG865050, BG865050.191.5955 84.6957 9 .4564
TWIST1 Mouse BC083139, BC083139.1, BU518900, BU518900.1106.147 04.772 111.197
YAP1 Mouse BC014733, BC014733.1, BF786662, BF786662.111 .289 25.494 1 8.685
ZBTB7A Mouse BC024815, BC024815.2, BI686387, BI686387.1132.658 97.919 113.275
ABL1 Not Available
AFF3 Not Available
APP Not Available
BACH2 Not Available
BCL11B Not Available
CAMTA1 Not Available
CEBPD Not Available
CHD5 Not Available
CREBBP Not Available
CTCF Not Available
DLX5 Not Available
DMTF1 Not Available
EGFR Not Available
EGR1 Not Available
ENO1 Not Available
ERBB4 Not Available
ETS1 Not Available
FLI1 Not Available
FOXA1 Not Available
FOXG1 Not Available
FOXP1 Not Available
GLI1 Not Available
GLI2 Not Available
GLI3 Not Available
HBP1 Not Available
HDAC2 Not Available
HIC1 Not Available
HIF1A Not Available
HNF4A Not Available
HOPX Not Available
IFI16 Not Available
IKZF3 Not Available
KLF10 Not Available
LMO4 Not Available
LZTS1 Not Available
MAPK1 Not Available
MBD2 Not Available
MXI1 Not Available
MYB Not Available
MYBL1 Not Available
MYBL2 Not Available
MYCN Not Available
NDN Not Available
NFYA Not Available
NOTCH1 Not Available
NR4A3 Not Available
OTX2 Not Available
PARP1 Not Available
PATZ1 Not Available
PAX2 Not Available
PAX6 Not Available
PAX8 Not Available
PBRM1 Not Available
PCGF2 Not Available
PDX1 Not Available
PHB Not Available
PHOX2A Not Available
PLAGL1 Not Available
POU6F2 Not Available
PRDM1 Not Available
PRDM4 Not Available
PRMT5 Not Available
PROX1 Not Available
RBL2 Not Available
REL Not Available
RNF6 Not Available
RUNX2 Not Available
SAFB Not Available
SAFB2 Not Available
SET Not Available
SMAD4 Not Available
SMARCA2 Not Available
SMARCA4 Not Available
SMARCB1 Not Available
SMARCE1 Not Available
SOD2 Not Available
SOX4 Not Available
SOX7 Not Available
SSBP2 Not Available
SUZ12 Not Available
TCF3 Not Available
TET1 Not Available
TET2 Not Available
TFAP2A Not Available
THRA Not Available
TP53 Not Available
TP53BP1 Not Available
TP63 Not Available
TP73 Not Available
TSPYL2 Not Available
UBTF Not Available
WNT1 Not Available
WNT5A Not Available
YEATS4 Not Available
ZEB2 Not Available
ZIC1 Not Available
